Testing effectiveness (Phase 2)Study completedNCT00741637
What this trial is testing
Safety and Immunogenicity of Single Dose Choleragarde® in HIV-Seropositive Adults
Who this might be right for
CholeraVibrio InfectionsDiarrhea
International Vaccine Institute 32